Eli Lilly (LLY) PT Raised to $1,205 at Cantor Fitzgerald
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,213.91 +1.86%
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 6 | New: 18
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 6 | New: 18
Join SI Premium – FREE
Cantor Fitzgerald analyst Carter Gould raised the price target on Eli Lilly (NYSE: LLY) to $1,205.00 (from $985.00) while maintaining a Overweight rating.
You May Also Be Interested In
- A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
- Truist Securities Downgrades Procept BioRobotics Corp (PRCT) to Hold
- Innovent and Lilly strike China deal for breast cancer drug
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
